Home › Funds › Casdin Capital › FDMT
Casdin Capital position in FDMT
4D MOLECULAR THERAPEUTICS IN · Health Care
Latest position (Q4 2024)1.15M sh
Reported value held$6.41M
Portfolio Weight0.43%
First reportedQ3 2021
Last changeHold
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 1.12M | $30.08M | New |
| Q4 2021 | 555.46K | $12.19M | Reduce |
| Q1 2022 | 555.46K | $8.40M | Hold |
| Q2 2022 | 555.46K | $3.88M | Hold |
| Q4 2022 | 630.00K | $13.99M | New |
| Q1 2023 | 1.07M | $18.39M | Add |
| Q2 2023 | 1.07M | $19.33M | Hold |
| Q3 2023 | 1.03M | $13.16M | Reduce |
| Q4 2023 | 1.03M | $20.95M | Hold |
| Q1 2024 | 800.00K | $25.49M | Reduce |
| Q2 2024 | 800.00K | $16.79M | Hold |
| Q3 2024 | 1.15M | $12.43M | Add |
| Q4 2024 | 1.15M | $6.41M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding FDMT
- BlackRock Inc 4.55M sh · $60.46M · Q2 2026
- Goldman Sachs Group 4.26M sh · $56.64M · Q2 2026
- Janus Henderson Group 5.25M sh · $48.87M · Q1 2026
- Vanguard Group 3.09M sh · $23.20M · Q4 2025
- Geode Capital Management 1.13M sh · $15.01M · Q2 2026
- Bank of America Corp 1.12M sh · $14.90M · Q2 2026
- Deutsche Bank AG 710.94K sh · $9.46M · Q2 2026
- Renaissance Technologies 614.57K sh · $8.17M · Q2 2026
- Northern Trust Corp 562.93K sh · $7.49M · Q2 2026
- Morgan Stanley 503.02K sh · $6.69M · Q2 2026
- JPMorgan Chase & Co 402.14K sh · $5.18M · Q2 2026
- Charles Schwab Investment Management 339.27K sh · $4.51M · Q2 2026